Sort
40,608 grants matching “prostate cancer”
NHGRI/DIR Genomics Core
$1,500,427Andreas Baxevanis · National Human Genome Research Institute · Z01 · FY2008 · HG
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
$1,500,153Lynn M Matrisian · Vanderbilt University · U54 · FY2008 · CA
Clinical Nursing and Data Management Core
$1,500,042William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2008 · CA
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2009 · CA
Southern Community Cohort Study
$1,500,000William J. Blot · Vanderbilt University · R01 · FY2006 · CA
JOHNS HOPKINS CENTER FOR CANCER COMPLEMENTARY MEDICINE
$1,500,000Johns Hopkins University · P50 · FY2000 · AT
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2010 · CA
Southwest Oncology Group--CCOP Research Base
$1,500,000Cancer Therapy And Research Center · U10 · FY2001 · CA
Baylor College of Medicine Cancer Center
$1,500,000C Kent Osborne · Baylor College Of Medicine · P30 · FY2007 · CA
Study of hereditary prostate cancer and human artificial chromosomes
$1,499,749Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
$1,499,199Marcia R Cruz Correa · University Of Puerto Rico Med Sciences · U54 · FY2014 · CA
Howard/Hopkins Cancer Center Partnership
$1,498,812Howard University · U54 · FY2002 · CA
CIDR - UPGRADE WHOLE GENOME SEQUENCING ON 2,294 EXPERIMENTAL DNA SAMPLES FOR NCI, BEEBE-DIMMER
$1,498,500Kimberly F Doheny · Johns Hopkins University · N01 · FY2023 · HL
ELUCIDATING MOLECULAR MECHANISMS OF TUMOR-IMMUNE DYNAMICS AND EVOLUTION IN RESPONSE TO RADIATION TO OPTIMIZE TREATMENT OF HIGH- AND VERY HIGH-RISK PROSTATE CANCER
$1,498,368The General Hospital Corporation · · FY2025 · Defense Health Agency
Physical and Biological Determinants for Optimal PDT
$1,497,936Massachusetts General Hospital · P01 · FY2003 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY
$1,497,565University Of California Davis · P01 · FY2000 · CA
TAS::75 0849::TAS SBIR TOPIC 255 PHASE II DEVELOPMENT OF ANTICANCER AGENTS
$1,496,764Catherine Burkhart · Buffalo Biolabs, Llc · N44 · FY2011 · CA
Proteases in Cancer Biology and Drug Development
$1,496,461University Of California San Francisco · P01 · FY2003 · CA
NATIONAL BLACK LEADERSHIP INITIATIVE ON CANCER II: NETWO
$1,495,577Morehouse School Of Medicine · U01 · FY2003 · CA
Metro-Minnesota Community Clinical Oncology Program
$1,493,996Patrick James Flynn · Park Nicollet Institute · U10 · FY2008 · CA
Novel Targets for Immunotherapy
$1,493,975Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
UNMC Eppley Cancer Center Support Grant
$1,493,701Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2007 · CA
UNMC Eppley Cancer Center Support Grant
$1,493,508Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2006 · CA
Molecular Assays for epidemiology studies
$1,493,361David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA